# Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults

> **NCT01464125** · PHASE2 · UNKNOWN · sponsor: **Jomaa Pharma GmbH** · enrollment: 43 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Fosmidomycin
- **DRUG:** Azithromycin

## Key facts

- **NCT ID:** NCT01464125
- **Lead sponsor:** Jomaa Pharma GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-11
- **Primary completion:** 2009-10
- **Final completion:** 2011-12
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2011-11-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01464125

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01464125, "Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01464125. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*